In Epithelial Ovarian Cancer, ADCmedian demonstrates good repeatability at both primary and metastatic sites. After neoadjuvant chemotherapy, a differential increase in ADCmedian at disease sites is seen despite similar tumor shrinkage. The negative correlation between ADCmedian and tumor cell fraction after neoadjuvant chemotherapy, and positive correlation between change in ADCmedian and percentage necrosis, are driven primarily by changes in the peritoneal lesions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords